Document:

EXHIBIT 4.2

                                    ATNG INC.
           NON-EMPLOYEE DIRECTORS AND CONSULTANTS RETAINER STOCK PLAN

                             FOR THE YEAR 2003 NO. 4

     1.     Introduction.  This  Plan  shall  be  known  as  the  "ATNG  Inc.
            ------------
Non-Employee Directors and Consultants Retainer Stock Plan for the Year 2003 No.
4," and is hereinafter referred to as the "Plan."  The purposes of this Plan are
to  enable  ATNG  Inc.,  a  Nevada  corporation  (the "Company"), to promote the
interests  of  the  Company  and  its  stockholders  by attracting and retaining
non-employee  Directors and Consultants capable of furthering the future success
of  the Company and by aligning their economic interests more closely with those
of  the  Company's stockholders, by paying their retainer or fees in the form of
shares  of  the  Company's common stock, par value $0.001 per share (the "Common
Stock").

     2.     Definitions.  The  following  terms  shall  have  the  meanings set
            -----------
forth  below:

     "Board" means the Board of Directors of the Company.

     "Change of Control" has the meaning set forth in Paragraph 13(d) hereof.

     "Code"  means  the Internal Revenue Code of 1986, as amended, and the rules
and  regulations  thereunder. References to any provision of the Code or rule or
regulation  thereunder  shall  be  deemed  to  include  any amended or successor
provision,  rule  or  regulation.

     "Committee"  means  the committee that administers this Plan, as more fully
defined  in  Paragraph  14  hereof.

     "Common Stock" has the meaning set forth in Paragraph 1 hereof.

     "Company" has the meaning set forth in Paragraph 1 hereof.

     "Deferral Election" has the meaning set forth in Paragraph 7 hereof.

     "Deferred  Stock  Account"  means  a  bookkeeping account maintained by the
Company  for a Participant representing the Participant's interest in the shares
credited  to  such  Deferred  Stock  Account  pursuant  to  Paragraph  8 hereof.

     "Delivery Date" has the meaning set forth in Paragraph 7 hereof.

     "Director" means an individual who is a member of the Board of Directors of
the  Company.

     "Dividend  Equivalent"  for  a given dividend or other distribution means a
number  of  shares  of  the  Common  Stock having a Fair Market Value, as of the
record date for such dividend or distribution, equal to the amount of cash, plus
the  Fair  Market  Value  on  the  date of distribution of any property, that is
distributed  with  respect  to  one  share  of the Common Stock pursuant to such
dividend  or  distribution;  such  Fair  Market  Value  to  be determined by the
Committee  in  good  faith.

     "Effective Date" has the meaning set forth in Paragraph 3 hereof.

     "Exchange Act" has the meaning set forth in Paragraph 13(d) hereof.

     "Fair  Market Value" means the mean between the highest and lowest reported
sales  prices  of the Common Stock on the New York Stock Exchange Composite Tape
or, if not listed on such exchange, on any other national securities exchange on
which  the  Common  Stock is listed or on The Nasdaq Stock Market, or, if not so

                                        1
<PAGE>
listed  on  any  other  national securities exchange or The Nasdaq Stock Market,
then  the  average  of  the  bid  price of the Common Stock during the last five
trading  days  on  the OTC Bulletin Board immediately preceding the last trading
day  prior  to  the  date  with  respect to which the Fair Market Value is to be
determined.  If  the  Common  Stock  is  not then publicly traded, then the Fair
Market  Value  of  the  Common  Stock shall be the book value of the Company per
share  as  determined  on the last day of March, June, September, or December in
any  year  closest  to  the  date  when the determination is to be made. For the
purpose  of  determining book value hereunder, book value shall be determined by
adding  as  of  the  applicable date called for herein the capital, surplus, and
undivided  profits  of  the  Company,  and  after  having  deducted any reserves
theretofore  established;  the sum of these items shall be divided by the number
of shares of the Common Stock outstanding as of said date, and the quotient thus
obtained shall represent the book value of each share of the Common Stock of the
Company.

     "Participant" has the meaning set forth in Paragraph 4 hereof.

     "Payment  Time"  means  the  time  when  a  Stock  Retainer is payable to a
Participant  pursuant to Paragraph 5 hereof (without regard to the effect of any
Deferral  Election).

     "Stock Retainer" has the meaning set forth in Paragraph 5 hereof.

     "Third Anniversary" has the meaning set forth in Paragraph 7 hereof.

     3.     Effective  Date  of  the  Plan.  This  Plan was adopted by the Board
            ------------------------------
effective  October  13,  2003  (the  "Effective  Date").

     4.     Eligibility.  Each  individual  who  is a  Director or Consultant on
            -----------
the  Effective  Date  and  each  individual who becomes a Director or Consultant
thereafter  during  the  term  of  this  Plan,  shall  be  a  participant  (the
"Participant")  in this Plan, in each case during such period as such individual
remains a Director or Consultant and is not an employee of the Company or any of
its  subsidiaries.  Each  credit  of shares of the Common Stock pursuant to this
Plan shall be evidenced by a written agreement duly executed and delivered by or
on  behalf of the Company and a Participant, if such an agreement is required by
the  Company  to  assure  compliance  with  all applicable laws and regulations.

     5.     Grants  of  Shares.  Commencing on the Effective Date, the amount of
            ------------------
compensation  for service to directors or consultants shall be payable in shares
of  the  Common  Stock  (the  "Stock  Retainer")  pursuant  to  this  Plan.

     6.     Purchase Price.  The purchase price (the "Exercise Price") of shares
            --------------
of the  Common Stock subject to each Stock Option (the "Option Shares") shall be
determined  by  the  board of directors acting in good faith, which in any event
shall not be less than 85 percent of the Fair Market Value of the Option Shares,
and in the case of any Participant who owns securities of the Company possessing
more  than  10  percent  of  the  total  combined voting power of all classes of
securities of the Company or its parent or subsidiaries possessing voting power,
the Exercise Price shall be at least 100 percent of the Fair Market Value of the
Option  Shares  at  the  time a Participant is granted the right to purchase the
Option  Shares,  or  at  the  time  the  purchase  is  consummated.

     7.     Deferral  Option.  From  and after the Effective Date, a Participant
            ----------------
may  make  an  election  (a  "Deferral  Election")  on  an annual basis to defer
delivery  of  the  Stock Retainer specifying which one of the following ways the
Stock Retainer is to be delivered (a) on the date which is three years after the
Effective  Date  for  which it was originally payable (the "Third Anniversary"),
(b) on the date upon which the Participant ceases to be a Director or Consultant
for  any  reason (the "Departure Date") or (c) in five equal annual installments
commencing  on  the Departure Date (the "Third Anniversary" and "Departure Date"
each  being  referred  to  herein  as a "Delivery Date"). Such Deferral Election
shall  remain  in effect for each Subsequent Year unless changed, provided that,
any  Deferral Election with respect to a particular Year may not be changed less
than six months prior to the beginning of such Year, and provided, further, that
no  more  than  one Deferral Election or change thereof may be made in any Year.

     Any Deferral Election and any change or revocation thereof shall be made by
delivering  written  notice  thereof  to  the Committee no later than six months
prior  to  the  beginning  of  the  Year  in  which  it  is  to  be  effected;

                                        2
<PAGE>
provided  that,  with  respect  to the Year beginning on the Effective Date, any
Deferral  Election  or  revocation  thereof  must be delivered no later than the
close  of  business  on  the  30th  day  after  the  Effective  Date.

     8.     Deferred  Stock  Accounts.  The  Company  shall  maintain a Deferred
            -------------------------
Stock  Account for each Participant who makes a Deferral Election to which shall
be  credited,  as  of  the  applicable Payment Time, the number of shares of the
Common  Stock  payable  pursuant  to  the  Stock  Retainer to which the Deferral
Election  relates.  So  long  as any amounts in such Deferred Stock Account have
not  been  delivered  to the Participant under Paragraph 9 hereof, each Deferred
Stock  Account shall be credited as of the payment date for any dividend paid or
other  distribution  made  with  respect  to  the Common Stock, with a number of
shares of the Common Stock equal to (a) the number of shares of the Common Stock
shown  in  such  Deferred  Stock Account on the record date for such dividend or
distribution  multiplied  by  (b)  the  Dividend Equivalent for such dividend or
distribution.

     9.     Delivery  of  Shares.
            --------------------

          (a)     The  shares  of  the  Common Stock in a Participant's Deferred
Stock  Account  with respect to any Stock Retainer for which a Deferral Election
has  been  made (together with dividends attributable to such shares credited to
such  Deferred  Stock  Account)  shall  be  delivered  in  accordance  with this
Paragraph  9  as  soon as practicable after the applicable Delivery Date. Except
with  respect to a Deferral Election pursuant to Paragraph 7(c) hereof, or other
agreement  between  the  parties,  such  shares  shall be delivered at one time;
provided that, if the number of shares so delivered includes a fractional share,
such  number  shall  be  rounded  to  the nearest whole number of shares. If the
Participant has in effect a Deferral Election pursuant to Paragraph 7(c) hereof,
then  such shares shall be delivered in five equal annual installments (together
with  dividends  attributable  to  such  shares  credited to such Deferred Stock
Account),  with  the  first  such  installment  being  delivered  on  the  first
anniversary  of  the  Delivery Date; provided that, if in order to equalize such
installments,  fractional  shares  would have to be delivered, such installments
shall be adjusted by rounding to the nearest whole share. If any such shares are
to  be  delivered  after the Participant has died or become legally incompetent,
they  shall  be  delivered to the Participant's estate or legal guardian, as the
case may be, in accordance with the foregoing; provided that, if the Participant
dies  with  a Deferral Election pursuant to Paragraph 7(c) hereof in effect, the
Committee  shall  deliver  all remaining undelivered shares to the Participant's
estate  immediately. References to a Participant in this Plan shall be deemed to
refer  to  the  Participant's  estate  or  legal  guardian,  where  appropriate.

          (b)     The  Company  may,  but  shall  not  be  required to, create a
grantor  trust or utilize an existing grantor trust (in either case, "Trust") to
assist  it  in accumulating the shares of the Common Stock needed to fulfill its
obligations  under  this  Paragraph  9.  However,  Participants  shall  have  no
beneficial  or  other  interest  in  the Trust and the assets thereof, and their
rights  under this Plan shall be as general creditors of the Company, unaffected
by  the  existence or nonexistence of the Trust, except that deliveries of Stock
Retainers  to  Participants  from  the  Trust  shall,  to the extent thereof, be
treated  as  satisfying  the  Company's  obligations  under  this  Paragraph  9.

     10.     Share  Certificates; Voting and Other Rights.  The certificates for
             --------------------------------------------
shares  delivered to a Participant pursuant to Paragraph 9 above shall be issued
in the name of the Participant, and from and after the date of such issuance the
Participant shall be entitled to all rights of a stockholder with respect to the
Common Stock for all such shares issued in his name, including the right to vote
the  shares,  and  the  Participant  shall  receive  all  dividends  and  other
distributions  paid  or  made  with  respect  thereto.

     11.     General  Restrictions.
             ---------------------

          (a)     Notwithstanding any other provision of this Plan or agreements
made pursuant thereto, the Company shall not be required to issue or deliver any
certificate or certificates for shares of the Common Stock under this Plan prior
to  fulfillment  of  all  of  the  following  conditions:

               (i)     Listing or approval for listing  upon  official notice of
issuance  of  such  shares  on  the New York Stock Exchange, Inc., or such other
securities  exchange  as  may  at  the  time  be  a market for the Common Stock;

                                        3
<PAGE>
               (ii)     Any  registration  or other qualification of such shares
under  any  state  or federal law or regulation, or the maintaining in effect of
any such registration or other qualification which the Committee shall, upon the
advice  of  counsel,  deem  necessary  or  advisable;  and

               (iii)     Obtaining  any  other consent, approval, or permit from
any  state  or  federal  governmental  agency  which  the Committee shall, after
receiving the advice of counsel, determine to be necessary or advisable.

          (b)     Nothing  contained in this Plan shall prevent the Company from
adopting other or additional compensation arrangements for the Participants.

     12.     Shares  Available.  Subject  to  Paragraph  13  below,  the maximum
             -----------------
number of shares of the Common Stock which may in the aggregate be paid as Stock
Retainers  pursuant  to  this  Plan  is  12,000,000.  Shares of the Common Stock
issuable  under  this  Plan  may be taken from treasury shares of the Company or
purchased  on  the  open  market.

     13.     Adjustments;  Change  of  Control.
             ---------------------------------

          (a)     In the event that there is, at any time after the Board adopts
this  Plan,  any  change  in  corporate  capitalization,  such as a stock split,
combination  of  shares,  exchange  of  shares,  warrants  or rights offering to
purchase  the  Common  Stock  at  a  price  below  its  Fair  Market  Value,
reclassification,  or  recapitalization, or a corporate transaction, such as any
merger,  consolidation,  separation,  including  a  spin-off, stock dividend, or
other  extraordinary  distribution  of  stock  or  property  of the Company, any
reorganization  (whether  or not such reorganization comes within the definition
of  such term in Section 368 of the Code) or any partial or complete liquidation
of  the Company (each of the foregoing a "Transaction"), in each case other than
any  such  Transaction which constitutes a Change of Control (as defined below),
(i)  the  Deferred  Stock Accounts shall be credited with the amount and kind of
shares  or  other  property  which  would  have been received by a holder of the
number  of  shares  of  the Common Stock held in such Deferred Stock Account had
such  shares of the Common Stock been outstanding as of the effectiveness of any
such  Transaction,  (ii) the number and kind of shares or other property subject
to  this  Plan  shall  likewise  be  appropriately  adjusted  to  reflect  the
effectiveness  of  any  such  Transaction,  and  (iii)  the  Committee  shall
appropriately  adjust  any  other  relevant provisions of this Plan and any such
modification  by  the  Committee shall be binding and conclusive on all persons.

          (b)     If  the  shares  of  the Common Stock credited to the Deferred
Stock  Accounts  are  converted pursuant to Paragraph 13(a) into another form of
property,  references  in  this  Plan to the Common Stock shall be deemed, where
appropriate,  to  refer  to  such  other  form  of  property,  with  such  other
modifications as may be required for this Plan to operate in accordance with its
purposes.  Without  limiting  the  generality  of  the  foregoing, references to
delivery of certificates for shares of the Common Stock shall be deemed to refer
to delivery of cash and the incidents of ownership of any other property held in
the  Deferred  Stock  Accounts.

          (c)     In  lieu of the adjustment contemplated by Paragraph 13(a), in
the  event  of a Change of Control, the following shall occur on the date of the
Change  of Control (i) the shares of the Common Stock held in each Participant's
Deferred  Stock  Account  shall be deemed to be issued and outstanding as of the
Change  of Control; (ii) the Company shall forthwith deliver to each Participant
who  has  a  Deferred Stock Account all of the shares of the Common Stock or any
other property held in such Participant's Deferred Stock Account; and (iii) this
Plan  shall  be  terminated.

          (d)     For purposes of this Plan, Change of Control shall mean any of
the following  events:

               (i)     The  acquisition  by  any  individual,  entity  or  group
(within  the  meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange
Act  of  1934,  as  amended  (the  "Exchange  Act"))  (a "Person") of beneficial
ownership  (within the meaning of Rule 13d-3 promulgated under the Exchange Act)
of  20  percent  or more of either (1) the then outstanding shares of the Common
Stock  of  the  Company  (the  "Outstanding  Company  Common Stock"), or (2) the
combined  voting  power  of  then  outstanding  voting securities of the Company
entitled  to  vote  generally  in  the  election  of directors (the "Outstanding
Company  Voting  Securities");  provided,

                                        4
<PAGE>
however,  that  the  following  acquisitions  shall  not  constitute a Change of
Control  (A) any acquisition directly from the Company (excluding an acquisition
by virtue of the exercise of a conversion privilege unless the security being so
converted was itself acquired directly from the Company), (B) any acquisition by
the Company, (C) any acquisition by any employee benefit plan (or related trust)
sponsored  or  maintained  by  the  Company or any corporation controlled by the
Company  or (D) any acquisition by any corporation pursuant to a reorganization,
merger  or  consolidation,  if,  following  such  reorganization,  merger  or
consolidation, the conditions described in clauses (A), (B) and (C) of paragraph
(iii)  of  this  Paragraph  13(d)  are  satisfied;  or

               (ii)     Individuals  who,  as of the date hereof, constitute the
Board  of  the  Company (as of the date hereof, "Incumbent Board") cease for any
reason  to  constitute at least a majority of the Board; provided, however, that
any individual becoming a director subsequent to the date hereof whose election,
or nomination for election by the Company's stockholders, was approved by a vote
of  at  least  a  majority  of the directors then comprising the Incumbent Board
shall  be  considered  as  though such individual were a member of the Incumbent
Board,  but  excluding,  for  this  purpose,  any  such individual whose initial
assumption  of  office  occurs  as  a  result  of either an actual or threatened
election  contest  (as  such  terms  are  used  in Rule 14a-11 of Regulation 14A
promulgated  under  the Exchange Act) or other actual or threatened solicitation
of  proxies  or  consents  by  or on behalf of a Person other than the Board; or

               (iii)     Approval  by  the  stockholders  of  the  Company  of a
reorganization,  merger,  binding  share  exchange  or  consolidation,  unless,
following  such  reorganization, merger, binding share exchange or consolidation
(1)  more  than  60  percent of, respectively, then outstanding shares of common
stock  of  the  corporation  resulting from such reorganization, merger, binding
share  exchange  or  consolidation  and  the  combined  voting  power  of  then
outstanding  voting securities of such corporation entitled to vote generally in
the election of directors is then beneficially owned, directly or indirectly, by
all or substantially all of the individuals and entities who were the beneficial
owners,  respectively,  of  the Outstanding Company Common Stock and Outstanding
Company  Voting  Securities  immediately  prior  to such reorganization, merger,
binding share exchange or consolidation in substantially the same proportions as
their ownership, immediately prior to such reorganization, merger, binding share
exchange  or  consolidation,  of  the  Outstanding  Company  Common  Stock  and
Outstanding  Company  Voting  Securities,  as  the  case  may  be, (2) no Person
(excluding  the  Company,  any  employee  benefit plan (or related trust) of the
Company  or such corporation resulting from such reorganization, merger, binding
share  exchange or consolidation and any Person beneficially owning, immediately
prior  to  such reorganization, merger, binding share exchange or consolidation,
directly  or  indirectly,  20  percent or more of the Outstanding Company Common
Stock or Outstanding Company Voting Securities, as the case may be) beneficially
owns,  directly  or  indirectly,  20  percent  or  more  of,  respectively, then
outstanding  shares  of  common  stock  of  the  corporation resulting from such
reorganization,  merger, binding share exchange or consolidation or the combined
voting  power of then outstanding voting securities of such corporation entitled
to  vote  generally in the election of directors, and (3) at least a majority of
the  members  of  the  board of directors of the corporation resulting from such
reorganization,  merger, binding share exchange or consolidation were members of
the  Incumbent  Board  at  the  time  of  the execution of the initial agreement
providing  for  such  reorganization,  merger,  binding  share  exchange  or
consolidation;  or

               (iv)     Approval  by  the  stockholders  of the Company of (1) a
complete  liquidation  or  dissolution  of the Company, or (2) the sale or other
disposition of all or substantially all of the assets of the Company, other than
to  a  corporation,  with  respect  to  which  following  such  sale  or  other
disposition,  (A) more than 60 percent of, respectively, then outstanding shares
of  common  stock  of  such  corporation  and  the combined voting power of then
outstanding  voting securities of such corporation entitled to vote generally in
the election of directors is then beneficially owned, directly or indirectly, by
all or substantially all of the individuals and entities who were the beneficial
owners,  respectively,  of  the Outstanding Company Common Stock and Outstanding
Company Voting Securities immediately prior to such sale or other disposition in
substantially  the same proportion as their ownership, immediately prior to such
sale  or  other  disposition,  of  the  Outstanding  Company  Common  Stock  and
Outstanding  Company  Voting  Securities,  as  the  case  may  be, (B) no Person
(excluding  the  Company and any employee benefit plan (or related trust) of the
Company  or  such  corporation  and  any Person beneficially owning, immediately
prior  to  such sale or other disposition, directly or indirectly, 20 percent or
more  of  the  Outstanding  Company  Common  Stock or Outstanding Company Voting
Securities,  as  the  case may be) beneficially owns, directly or indirectly, 20
percent  or  more  of,  respectively, then outstanding shares of common stock of
such  corporation  and  the  combined  voting  power  of then outstanding voting
securities  of  such  corporation  entitled to vote generally in the election of
directors,  and (3) at least a majority of the members of the board of directors
of  such  corporation  were  members  of  the

                                        5
<PAGE>
Incumbent  Board at the time of the execution of the initial agreement or action
of  the  Board  providing  for  such  sale or other disposition of assets of the
Company.

     14.     Administration;  Amendment  and  Termination.
             --------------------------------------------

          (a)     This  Plan  shall be administered by a committee consisting of
two  members  who  shall  be  the  current  directors  of  the Company or senior
executive  officers  or  other  directors  who  are  not  Participants as may be
designated  by  the  Chief Executive Officer (the "Committee"), which shall have
full  authority  to  construe  and  interpret this Plan, to establish, amend and
rescind  rules  and  regulations  relating  to  this  Plan, and to take all such
actions  and make all such determinations in connection with this Plan as it may
deem  necessary  or  desirable.

          (b)     The  Board  may from time to time make such amendments to this
Plan,  including  to  preserve or come within any exemption from liability under
Section  16(b)  of  the  Exchange  Act,  as  it  may deem proper and in the best
interest  of the Company without further approval of the Company's stockholders,
provided  that,  to  the  extent  required  under  Nevada  law  or  to  qualify
transactions  under  this  Plan for exemption under Rule 16b-3 promulgated under
the  Exchange  Act,  no  amendment to this Plan shall be adopted without further
approval  of  the  Company's stockholders and, provided, further, that if and to
the  extent  required  for this Plan to comply with Rule 16b-3 promulgated under
the  Exchange Act, no amendment to this Plan shall be made more than once in any
six  month period that would change the amount, price or timing of the grants of
the  Common  Stock hereunder other than to comport with changes in the Code, the
Employee  Retirement Income Security Act of 1974, as amended, or the regulations
thereunder.  The  Board  may  terminate  this  Plan  at  any time by a vote of a
majority  of  the  members  thereof.

     15.     Restrictions  on  Transfer.  Each  Stock  Option granted under this
             --------------------------
Plan shall be transferable only by will or the laws of descent and distribution.
No  interest  of  any  Employee  under this Plan shall be subject to attachment,
execution, garnishment, sequestration, the laws of bankruptcy or any other legal
or  equitable  process.  Each  Stock  Option  granted  under  this Plan shall be
exercisable  during  an  Employee's  lifetime  only  by  the  Employee or by the
Employee's  legal  representative.

     16.     Term  of  Plan.  No  Stock  Option  shall  be exercisable, or Award
             --------------
granted,  unless  and until the Directors of the Company have approved this Plan
and  all  other  legal  requirements have been met. This Plan was adopted by the
Board  effective  October  13,  2003.  No Stock Options or Awards may be granted
under  this  Plan  after  October  13,  2013.

     17.     Approval.  This  Plan  must  be  approved  by  a  majority  of  the
             --------
outstanding  securities  entitled  to vote within 12 months before or after this
Plan  is  adopted  or  the  date  the  agreement is entered into. Any securities
purchased  before  security  holder  approval  is  obtained must be rescinded if
security  holder  approval is not obtained within 12 months before or after this
Plan  is  adopted or the agreement is entered into. Such securities shall not be
counted  in  determining  whether  such  approval  is  obtained.

     18.     Governing Law.  This Plan and all actions taken thereunder shall be
             -------------
governed  by, and construed in accordance with, the laws of the State of Nevada.

     19.     Information  to Shareholders.  The Company shall furnish to each of
             ----------------------------
its  stockholders  financial  statements  of  the  Company  at  least  annually.

     20.     Miscellaneous.
             -------------

          (a)     Nothing  in this Plan shall be deemed to create any obligation
on  the  part  of  the  Board  to  nominate  any  Director for reelection by the
Company's  stockholders or to limit the rights of the stockholders to remove any
Director.

          (b)     The  Company  shall  have  the  right to require, prior to the
issuance  or  delivery  of any shares of the Common Stock pursuant to this Plan,
that  a  Participant  make  arrangements  satisfactory  to the Committee for the
withholding  of  any  taxes  required  by law to be withheld with respect to the
issuance  or  delivery

                                        6
<PAGE>
of such shares, including, without limitation, by the withholding of shares that
would otherwise be so issued or delivered, by withholding from any other payment
due  to the Participant, or by a cash payment to the Company by the Participant.

     IN WITNESS WHEREOF, this Plan has been executed effective as of October 13,
2003.

                                                  ATNG INC.

                                                  By  /s/  Robert Simpson
                                                    ----------------------------
                                                    Robert Simpson, President

                                        7
<PAGE>Exhibit 4.22

     WARRANT  AGREEMENT  dated  as of September 15, 2003 between New York Health
Care,  Inc.,  a  New  York corporation (the "Company"), whose principal place of
business is 1850 MacDonald Avenue, Brooklyn, NY 11223 and _____________________,
his  successors,  designees  and  assigns  (the  "Holder").

                              W I T N E S S E T H:
                              - - - - - - - - - -

     WHEREAS,  the Company proposes to issue to the Holder a warrant to purchase
up  to  an aggregate of _________ shares of the Company's common stock, $.01 par
value,  (the  "Common  Stock") which shall be known as the "Series ___" Warrant.

     NOW, THEREFORE, in consideration of the premises, the agreements herein set
forth  and other good and valuable consideration, the receipt and sufficiency of
which  are  hereby  acknowledged,  the  parties  hereto  agree  as  follows:

     1.     GRANT.  The Company hereby agrees to issue to the Holder the warrant
            -----
described  in  Section  1.1  below.

     1.1     SERIES  __ WARRANT.  The Series __ Warrant grants to the Holder the
             ------------------
right to purchase, at any time from September 15, 2003 until 5:00 P.M., New York
time, on September 15, 2008, up to an aggregate of _______shares of Common Stock
(the  "Shares")  at an initial exercise price (subject to adjustment as provided
in  Section  8 hereof) of $3.69 per share subject to the terms and conditions of
    -------
this  Agreement.  Except  as set forth herein, the shares issuable upon exercise
of  the  Series__  Warrant are in all respects identical to the shares of Common
Stock  held  by  all  of  the  Company's  other  shareholders.

     2.     WARRANT  CERTIFICATE.  The  warrant  certificate  (the  "Warrant
            --------------------
Certificate")  delivered and to be delivered pursuant to this Agreement shall be
in the form set forth in Exhibit A, attached hereto and made a part hereof, with
such  appropriate  insertions, omissions, substitutions, and other variations as
required  or  permitted  by  this  Agreement.

<PAGE>
     3.     EXERCISE  OF  WARRANT.
            ---------------------

     3.1     METHOD  OF EXERCISE.  The Series__ Warrant is initially exercisable
             --------------------
at  the  initial  exercise price (subject to adjustment as provided in Section 8
hereof)  per  Share  payable  by  certified  or  official bank check in New York
Clearing  House  funds  or  by  surrender  to  the Company of a number of Shares
issuable  pursuant  to  the  Series__ Warrant which, when valued at the exercise
price,  equal  the amount of the exercise price for the Shares to be issued upon
exercise of the Series__ Warrant, subject to adjustment as provided in Section 8
hereof.  Upon  surrender  of  a  Warrant  Certificate  with  the annexed Form of
Election  to Purchase duly executed, together with payment of the Exercise Price
(as  hereinafter  defined)  for  the  Common  Stock  purchased  at the Company's
principal  offices  (presently  located  at  1850 MacDonald Avenue, Brooklyn, NY
11223)  the  registered  holder of a Warrant Certificate ("Holder" or "Holders")
shall  be  entitled  to  receive a certificate or certificates for the shares of
Common  Stock  so  purchased.  The  purchase  rights represented by each Warrant
Certificate  are  exercisable  at the option of the Holders thereof, in whole or
part  (but not as to fractional shares of the Common Stock).  In the case of the
purchase  of  less  than  all  Common  Stock  purchasable  under  any  Warrant
Certificate,  the  Company  shall  cancel  said  Warrant  Certificate  upon  the
surrender  thereof  and  shall  execute and deliver a new Warrant Certificate of
like  tenor  for  the  balance  of  the  Common  Stock  purchasable  thereunder.

     3.2     DEFINITION  OF  MARKET  PRICE.  As  used herein, the phrase "Market
             -----------------------------
Price" at any date shall be deemed to be (i) when referring to the Common Stock,
the  last  reported price, or, in case no such reported sale takes place on such
day,  the  average  of  the  last reported prices for the last three (3) trading
days, in either case as officially reported by the principal securities exchange
on  which  the  Common  Stock  is listed or admitted to trading or by the Nasdaq
Stock  Market ("NSM")  or, (ii) if the Common Stock is not listed or admitted to
trading  on  any  national  securities  exchange  or  quoted by NSM, the average
closing  price  as  furnished by the National Association of Securities Dealers,
Inc.  ("NASD")  through  Nasdaq  or  similar organization if Nasdaq is no longer
reporting  such  information,  or  (iii)  if  the  Common Stock is not quoted on
Nasdaq,  or  such similar organization as determined in good faith by resolution
of  the  Board  of  Directors  of  the  Company,  based  on the best information
available  to  it.

<PAGE>
     4.     ISSUANCE OF CERTIFICATE.  Upon the exercise of the Series__ Warrant,
            ------------------------
the  issuance of certificates for shares of Common Stock shall be made forthwith
(and  in  any  event within five (5) business days thereafter) without charge to
the  Holder  thereof including, without limitation, any tax which may be payable
in  respect of the issuance thereof, and such certificates shall (subject to the
provisions  of  Sections  5  and  7 hereof) be issued in the name of, or in such
names  as  may  be  directed by, the Holder thereof; provided, however, that the
Company  shall not be required to pay any tax which may be payable in respect of
any transfer involved in the issuance and delivery of any such certificates in a
name  other  than  that  of  the Holder and the Company shall not be required to
issue  or  deliver  such  certificates  unless  or  until  the person or persons
requesting  the  issuance  thereof  shall have paid to the Company the amount of
such  tax or shall have established to the satisfaction of the Company that such
tax  has  been  paid.

     The  Warrant  Certificate and the certificate representing the Shares shall
be executed on behalf of the Company by the manual or facsimile signature of the
then present Chairman or Vice Chairman of the Board of Directors or President or
Vice  President  of  the  Company  under  its corporate seal reproduced thereon,
attested  to  by the manual or facsimile signature of the then present Secretary
or  Assistant  Secretary of the Company.  The Warrant Certificate shall be dated
the  date of execution by the Company upon initial issuance, division, exchange,
substitution  or  transfer.

     5.     RESTRICTION  ON  TRANSFER  OF  WARRANTS.  The  Holder  of  a Warrant
            ---------------------------------------
Certificate,  by  its acceptance thereof, covenants and agrees that the Series__
Warrant  is  being  acquired  as  an  investment  and  not  with  a  view to the
distribution  thereof;  that  the Series__ Warrant may not be sold, transferred,
assigned,  hypothecated  or  otherwise  disposed  of, in whole or in part, for a
period  of  one  (1)  year  from  the  date  hereof.

     6.     EXERCISE  PRICE.
            ----------------

     6.1     INITIAL  AND ADJUSTED EXERCISE PRICE.  Except as otherwise provided
             ------------------------------------
in  Section  8  hereof,  the  initial exercise price of each Series__ Warrant to
purchase  Common Stock shall be equal to the initial exercise price set forth in
Sections  1.1  above.  The  adjusted  exercise  price

<PAGE>
shall  be  the  price  which  shall  result  from  time to time from any and all
adjustments  of  the initial exercise price in accordance with the provisions of
Section  8  hereof.

     6.2     EXERCISE  PRICE.  The  term  "Exercise Price" herein shall mean the
             ---------------
applicable  initial  exercise  price  or with respect to the Series__ Warrant to
purchase  Common  Stock  at  the  adjusted  exercise  price,  depending upon the
context.

     7.     REGISTRATION  RIGHTS.
            ---------------------

     7.1     CURRENT REGISTRATION UNDER THE SECURITIES ACT OF 1933.  The Company
             -----------------------------------------------------
has  registered certain shares of common stock under the Securities Act of 1933,
as  amended  (the  "Act")  (the  "Registration  Statement").

     7.2     PIGGYBACK  REGISTRATION.
             ------------------------

          (a)     If,  at  any time commencing after the date of this Agreement,
the Company proposes to register any of its securities under the Act, either for
its  own  account  or the account of any other security holder or holders of the
Company  possessing  registration  rights  ("Other Stockholders"), it shall give
written  notice,  at  least  thirty  (30)  days prior to the filing of each such
registration  statement, to the Holder and to all other Holders of warrants with
registration  rights  of the opportunity to register the Common Stock underlying
such  warrants  (collectively,  "Registrable Securities") of its intention to do
so.  If the Holder or other Holders of Registrable Securities notify the Company
within twenty-one (21) days after the receipt of any such notice of its or their
desire  to  include any such securities in such proposed registration statement,
the  Company  shall  afford the Holder and such other Holders of such securities
the  opportunity  to have any such securities registered under such registration
statement.

          (b)     If the registration of which the Company gives notice is for a
registered  public  offering  involving  an  underwriting,  the Company shall so
advise  the  Holder  and  such other Holders as part of the written notice given
pursuant  to  Section  7.2(a) hereof.  The right of the Holder or any such other
Holder  to  registration  pursuant to this Section 7.2 shall be conditioned upon
their  participation in such underwriting and the inclusion of their Registrable
Securities  in  the underwriting to the extent hereinafter provided.  The Holder
and  all  other  Holders  proposing  to distribute their securities through such
underwriting  shall  (together  with  the  Company and any officer, directors or
Other  Stockholders  distributing  their  securities  through

<PAGE>
such  underwriting)  enter into an underwriting agreement in customary form with
the  underwriter selected by the Company. Notwithstanding any other provision of
this  Section  7.2,  if  the  underwriter  advises  the  Company in writing that
marketing factors require a limitation or elimination of the number of shares of
Common  Stock  or other securities to be underwritten, the underwriter may limit
the  number  of shares of Common Stock or other securities to be included in the
registration  and  underwriting.  The Company shall so advise the Holder and all
other  Holders of Registrable Securities requesting registration, and the number
of  shares  of Common Stock or other securities that are entitled to be included
in  the  registration  and  underwriting shall be allocated among the Holder and
other Holders requesting registration, in each case, in proportion, as nearly as
practicable, to the respective amounts of securities which they had requested to
be  included  in  such  registration  at  the  time  of  filing the registration
statement.

          (c)     Notwithstanding  the  provisions  of  this  Section  7.2,  the
Company  shall  have  the  right  at  any time after it shall have given written
notice  pursuant  to  Section  7.2(a)  hereof (irrespective of whether a written
request  for inclusion of any such securities shall have been made) to elect not
to  file any such proposed registration statement, or to withdraw the same after
the filing but prior to the effective date thereof.

          7.3     COVENANTS  OF  THE  COMPANY  WITH RESPECT TO REGISTRATION.  In
                  ---------------------------------------------------------
connection  with  any  registration under Section 7.2, the Company covenants and
agrees  as  follows:

          (a)     The  Company  shall  use  its  best  efforts  to  have  any
registration  statement  declared  effective  at the earliest possible time, and
shall furnish each Holder desiring to sell Registrable Securities such number of
prospectuses  as  shall  reasonably  be  requested.

          (b)     The  Company  shall pay all costs (excluding fees and expenses
of  Holder(s)'  counsel  and  any underwriting or selling commissions), fees and
expenses  in  connection  with  all  registration  statements  filed pursuant to
Section  7.2  hereof  including,  without  limitation,  the  Company's legal and
accounting  fees,  printing  expenses,  blue  sky  fees  and  expenses.

          (c)     The  Company  will  take  all  necessary  action  which may be
required  in  qualifying or registering the Registrable Securities included in a
registration  statement  for  offering and sale under the securities or blue sky
laws  of  such  states  as  reasonably  are  requested

<PAGE>
by the Holder(s); provided that the Company shall not be obligated to execute or
file  any  general  consent  to  service  of  process or to qualify as a foreign
corporation to do business under the laws of any such jurisdiction.

          (d)     The  Company  shall indemnify the Holder(s) of the Registrable
Securities to be sold pursuant to any registration statement and each person, if
any,  who  controls  such Holders within the meaning of Section 15 of the Act or
Section  20(a)  of  the  Securities  Exchange Act of 1934, as amended ("Exchange
Act"),  against  all  loss,  claim,  damage, expense or liability (including all
expenses  reasonably  incurred  in investigating, preparing or defending against
any claim whatsoever) to which any of them may become subject under the Act, the
Exchange Act or otherwise, arising from such registration statement.

          (e)     The  Holder(s)  of  the  Registrable  Securities  to  be  sold
pursuant  to  a  registration statement, and their successors and assigns, shall
severally,  and  not  jointly, indemnify the Company, its officers and directors
and  each person, if any, who controls the Company within the meaning of Section
15  of  the  Act  or Section 20(a) of the Exchange Act, against all loss, claim,
damage  or  expense  or liability (including all expenses reasonably incurred in
investigating,  preparing  or  defending  against any claim whatsoever) to which
they  may  become  subject under the Act, the Exchange Act or otherwise, arising
from  information furnished by or on behalf of such Holders, or their successors
or assigns, for specific inclusion in such registration statement.

          (f)     For  purposes  of  this  Agreement,  the  term  "Majority"  in
reference  to  the  Holders  of  Registrable Securities, shall mean in excess of
fifty  percent (50%) of the Registrable Securities that  have not been resold to
the  public  pursuant  to  a registration statement filed with the SEC under the
Act.

          (g)     Nothing  contained  in  this  Agreement  shall be construed as
requiring  the Holder(s) to exercise their Series__ Warrant prior to the initial
filing of any registration statement or the effectiveness thereof.

     7.4     RESTRICTIVE  LEGENDS.  In  the  event  that  the  Company  fails to
             --------------------
maintain  the  effectiveness  of  the  Registration  Statement,  such  that  the
exercise,  in part or in whole, of the Series__ Warrants are not, at the time of
such  exercise,  registered  under  the  Act,  any  certificates

<PAGE>
representing  the  Shares  underlying the Series__ Warrants and any of the other
securities  issuable  upon  exercise  of  the  Series__  Warrants shall bear the
following  restrictive  legend:

     The  securities  represented  by  this  certificate  have  not  been
     registered  under  the Securities Act of 1933, as amended ("Act"), and
     may  not  be  offered  or  sold  except  pursuant  to (i) an effective
     registration  statement  under the Act, (ii) to the extent applicable,
     Rule 144 under the Act (or any similar rule under such Act relating to
     the  disposition  of  securities),  or (iii) an opinion of counsel, if
     such  opinion  shall  be  reasonably  satisfactory  to  counsel to the
     issuer,  that  an  exemption  from  registration  under  such  Act  is
     available.

     8.     ADJUSTMENTS  TO  EXERCISE  PRICE  AND  NUMBER  OF  SECURITIES.
            -------------------------------------------------------------

     8.1     SUBDIVISION AND COMBINATION.  In case the Company shall at any time
             ---------------------------
subdivide  or combine the outstanding shares of Common Stock, the Exercise Price
shall  forthwith  be  proportionately  decreased  in  the case of subdivision or
increased  in  the  case  of  combination.

     8.2     ADJUSTMENT  IN  NUMBER  OF SECURITIES.  Upon each adjustment of the
             -------------------------------------
Exercise  Price  pursuant  to  the  provisions  of this Section 8, the number of
Common  Stock  issuable upon the exercise at the adjusted exercise price of each
Series__  Warrant  shall be adjusted to the nearest full amount by multiplying a
number  equal  to  the  Exercise  Price  in  effect  immediately  prior  to such
adjustment  by the number of Common Stock issuable upon exercise of the Series__
Warrant  immediately  prior  to  such  adjustment  and  dividing  the product so
obtained  by  the  adjusted  Exercise  Price.

     8.3     DEFINITION OF COMMON STOCK.  For the purpose of this Agreement, the
             --------------------------
term "Common Stock" shall mean (i) the class of stock designated as Common Stock
in  the  Certificate  of  Incorporation of the Company as amended as of the date
hereof,  or  (ii)  any other class of stock resulting from successive changes or
reclassifications  of  such  Common  Stock  consisting  solely of changes in par
value,  or  from  par  value to no par value, or from no par value to par value.
The  Company  covenants  that  so  long  as  any  of  the  Series__  Warrant are
outstanding,  the  Company  shall  not  without the prior written consent of the
Holder  issue  any  securities whatsoever other than Common Stock.  In the event
that  the  Company  shall, upon the consent of the Holder, after the date hereof
issue  securities  with  greater  or  superior  voting rights than the shares of
Common  Stock  outstanding as of the date hereof, the Holder, at its option, may

<PAGE>
receive upon exercise of any Series__ Warrant either shares of Common Stock or a
like number of such securities with greater or superior voting rights.

     8.4     MERGER  OR  CONSOLIDATION.  In  case  of  any  consolidation of the
             -------------------------
Company  with,  or  merger  of  the Company with, or merger of the Company into,
another  corporation (other than a consolidation or merger which does not result
in  any  reclassification  or  change  of  the  outstanding  Common  Stock), the
corporation  formed by such consolidation or merger shall execute and deliver to
the  Holder  a  supplemental warrant agreement providing that the holder of each
Series__  Warrant  then  outstanding  or  to be outstanding shall have the right
thereafter  (until  the  expiration  of  such Series__ Warrant) to receive, upon
exercise  of  such  warrant,  the  kind  and amount of shares of stock and other
securities  and  property  receivable  upon  such  consolidation or merger, by a
holder  of  the  number  of shares of Common Stock of the Company for which such
Series__  Warrant  might  have  been  exercised  immediately  prior  to  such
consolidation,  merger,  sale  or transfer.  Such supplemental warrant agreement
shall  provide  for  adjustments  which  shall  be  identical to the adjustments
provided  in  Section 8.  The above provision of this subsection shall similarly
apply  to  successive  consolidations  or  mergers.

     8.5     NO ADJUSTMENT OF EXERCISE PRICE IN CERTAIN CASES.  No adjustment of
             ------------------------------------------------
the Exercise Price shall be made:

          (a)     upon  the  issuance  or  sale  of  the Series__ Warrant or the
shares of Common Stock issuable upon the exercise of the Series__ Warrant; or

          (b)      If  the  amount of said adjustment shall be less than two (2)
cents  per Warrant Security, provided, however, that in such case any adjustment
that  would  otherwise  be required then to be made shall be carried forward and
shall  be  made  at the time of and together with the next subsequent adjustment
which, together with any adjustment so carried forward, shall amount to at least
two  (2)  cents  per  Warrant  Security.

     9.     EXCHANGE  AND  REPLACEMENT  OF  WARRANT  CERTIFICATES.  Each Warrant
            -----------------------------------------------------
Certificate  is  exchangeable without expense, upon the surrender thereof by the
registered  Holder  at  the principal executive office of the Company, for a new
Warrant  Certificate  of  like  tenor and date representing in the aggregate the
right to purchase the same number of Common Stock in such denominations as shall
be designed by the Holder thereof at the time of such surrender.

<PAGE>
     Upon  receipt  by  the Company of evidence reasonably satisfactory to it of
the  loss,  theft, destruction or mutilation of any Warrant Certificate, and, in
case  of  loss,  theft  or  destruction,  of  indemnity  or  security reasonably
satisfactory  to it, and reimbursement to the Company of all reasonable expenses
incidental thereto, and upon surrender and cancellation of the Series__ Warrant,
if  mutilated,  the  Company  will make and deliver a new Warrant Certificate of
like  tenor,  in  lieu  thereof.

     10.     ELIMINATION  OF  FRACTIONAL  INTERESTS.  The  Company  shall not be
             --------------------------------------
required to issue fractional shares of Common Stock or the Series__ Warrant upon
the  exercise  of  the Series__ Warrant.  Warrants may only be exercised in such
multiples  as  are required to permit the issuance by the Company of one or more
whole  shares  of  Common  Stock.  If  one  or  more  Series__  Warrant shall be
presented  for  exercise in full at the same time by the same Holder, the number
of  whole  shares  of  Common  Stock  which shall be issuable upon such exercise
thereof  shall  be  computed  on  the basis of the aggregate number of shares of
Common  Stock  purchasable on exercise of the Series__ Warrant so presented.  If
any  fraction  of  a  share  of  Common  Stock  would, except for the provisions
provided  herein,  be  issuable  on  the  exercise  of  any Series__ Warrant (or
specified  portion  thereof),  the  Company shall pay an amount in cash equal to
such  fraction  multiplied by the then current market value of a share of Common
Stock,  determined  as  follows:

          (1)     If the Common Stock is listed, or admitted to unlisted trading
privileges  on  the  New  York  Stock  Exchange  ("NYSE")  or the American Stock
Exchange  ("AMEX"), or is traded on the NSM, the current market value of a share
of Common Stock  shall be the closing sale price of the Common Stock  at the end
of  the  regular  trading  session on the last business day prior to the date of
exercise  of  the Series__ Warrant on whichever of such exchanges or NSM had the
highest average daily trading volume for the Common Stock on such day; or

          (2)     If  the  Common  Stock  is  not listed or admitted to unlisted
trading privileges, on either the NYSE or the AMEX and is not traded on NSM, but
is  quoted  or reported on Nasdaq, the current market value of a share of Common
Stock  shall  be  the closing price (or the last sale price, if then reported by
Nasdaq)  of  the  Common  Stock  at  the  end  of  the  regular

<PAGE>
trading  session  on  the last business day prior to the date of exercise of the
Series__ Warrant as quoted or reported on Nasdaq; or

          (3)     If  the  Common  Stock  is not listed, or admitted to unlisted
trading  privileges, on either of the NYSE or the AMEX, and is not traded on NSM
or  quoted  or reported on Nasdaq, but is listed or admitted to unlisted trading
privileges  on  the  BSE or another national securities exchange (other than the
NYSE  or the AMEX), the current market value of a share of Common Stock shall be
the  closing price of the Common Stock at the end of the regular trading session
on  the  last business day prior to the date of exercise of the Series__ Warrant
on  whichever of such exchanges has the highest average daily trading volume for
the  Common  Stock  on  such  day;  or

          (4)     If  the  Common  Stock  is  not listed or admitted to unlisted
trading privileges on any national securities exchange, or listed for trading on
NSM  or  quoted  or  reported  on  Nasdaq, but is traded in the over-the-counter
market,  the  current  market  value  of  a  share of Common Stock  shall be the
average  of the last reported bid and asked prices of the Common Stock  reported
by  the  National  Quotation  Bureau, Inc. on the last business day prior to the
date  of  exercise  of  the  Series__  Warrant;  or

          (5)     If  the  Common  Stock  as  the  case  may  be, is not listed,
admitted  to unlisted trading privileges on any national securities exchange, or
listed  for  trading  on  NSM or quoted or reported on Nasdaq, and bid and asked
prices  of  the Common Stock  are not reported by the National Quotation Bureau,
Inc.,  the  current  market value of a share of Common Stock shall be an amount,
not  less  than  the  book  value  thereof  as  of  the end of the most recently
completed  fiscal  quarter  of the Company ending prior to the date of exercise,
determined  in  accordance  with  generally  acceptable  accounting  principles,
consistently  applied.

     11.     RESERVATION  AND  LISTING  OF SECURITIES.  The Company shall at all
             ----------------------------------------
times  reserve  and keep available out of its authorized shares of Common Stock,
solely  for  the  purpose  of issuance upon the exercise of the Series__ Warrant
such  number of shares of Common Stock or other securities, properties or rights
as  shall  be  issuable  upon  the  exercise thereof.  The Company covenants and
agrees  that,  upon exercise of the Series__ Warrant and payment of the Exercise
Price  therefore,  all shares of Common Stock and other Securities issuable upon
such  exercise

<PAGE>
shall  be duly and validly issued, fully paid, non-assessable and not subject to
the  preemptive rights of any stockholder. As long as the Series__ Warrant shall
be  outstanding,  the  Company shall use its best efforts to cause all shares of
Common  Stock  issuable  upon  the exercise of the Series__ Warrant to be listed
(subject  to  official  notice of issuance) on all securities exchanges on which
the  Common Stock issued to the public in connection herewith may then be listed
and  quoted  on  NSM.

     12.     NOTICES  TO  WARRANT  HOLDERS.  Nothing contained in this Agreement
             -----------------------------
shall  be  construed  as  conferring  upon  the  Holders the right to vote or to
consent  or  to  receive  notice  as a stockholder in respect of any meetings of
stockholders for the election of directors or any other matter, or as having any
rights  whatsoever  as  a  stockholder of the Company.  If, however, at any time
prior  to the expiration of the Series__ Warrants and their exercise, any of the
following  events  shall  occur:

          (a)     the  Company  shall take a record of the holders of its shares
of  Common  Stock  for  the  purpose  of entitling them to receive a dividend or
distribution  payable  other  than  in  cash, or a cash dividend or distribution
payable  other  than  out  of  current or retained earnings, as indicated by the
accounting  treatment  of  such  dividend  or  distribution  on the books of the
Company;  or

          (b)     the Company shall offer to all the holders of its Common Stock
any  additional shares of capital stock of the Company or securities convertible
into  or exchangeable for shares of capital stock of the Company, or any option,
right  or  warrant to subscribe therefore; or (c)  a dissolution, liquidation or
winding  up  of  the  Company  (other than in connection with a consolidation or
merger)  or  a  sale  of  all  or  substantially all of its property, assets and
business  as  an  entirety  shall  be proposed; then, in any one or more of said
events,  the  Company  shall  give written notice of such event at least fifteen
(15)  days  prior  to the date fixed as a record date or the date of closing the
transfer  books  for  the  determination  of  the  stockholders entitled to such
dividend,  distribution,  convertible or exchangeable securities or subscription
rights,  or  entitled to vote on such proposed dissolution, liquidation, winding
up  or  sale.  Such notice shall specify such record date or the date of closing
the  transfer  book,  as  the  case  may be.  Failure to give such notice or any
defect  therein  shall not affect the validity of any action taken in connection
with  the

<PAGE>
declaration  or payment of any such dividend, or the issuance of any convertible
or  exchangeable securities, or subscription rights, options or warrants, or any
proposed  dissolution,  liquidation,  winding  up  or  sale.

     13.     NOTICE.
             ------

     All notices, requests, consents and other communications hereunder shall be
in  writing  and shall be deemed to have been duly made and sent when delivered,
or mailed by registered or certified mail, return receipt requested:

          (a)     If  to  the  registered Holder of the Series__ Warrant, to the
address of such Holder as shown on the books of the Company; or

          (b)     If  to  the  Company,  to  the  address set forth in Section 3
hereof  or  to  such other address as the Company may designate by notice to the
Holders.

     14.     SUPPLEMENTS  AND  AMENDMENTS.  The  Company and the Holder may from
             ----------------------------
time  to  time  supplement  or  amend this Agreement without the approval of any
Holders  of  Warrant  Certificates in order to cure any ambiguity, to correct or
supplement any provision contained herein which may be defective or inconsistent
with any provisions herein, or to make any other provisions in regard to matters
or  questions  arising  hereunder  which  the  Company  and  the Holder may deem
necessary  or  desirable  and  which  the  Company and the Holder deem shall not
adversely  affect  the  interests  of  the  Holders  of  Warrant  Certificates.

     15.     SUCCESSORS.  All  the  covenants  and  provisions of this Agreement
             ----------
shall  be  binding upon and inure to the benefit of the Company, the Holders and
their respective successors and assigns hereunder.

     16.     TERMINATION.  This  Agreement  shall  terminate  at  the  close  of
             -----------
business  on  September  15,  2008.  Notwithstanding  the  foregoing,  the
indemnification provisions of Section 7 shall survive such termination until the
close of business on September 15, 2014.

<PAGE>
     17.     GOVERNING LAW; SUBMISSION TO JURISDICTION.  This Agreement and each
             -----------------------------------------
Warrant Certificate issued hereunder shall be deemed to be a contract made under
the  laws  of  the  State of New York and for all purposes shall be construed in
accordance  with  the  laws  of said State without giving effect to the rules of
said  State  governing  the  conflicts  of  laws.

     The  Company, the Holder and any other registered Holders hereby agree that
any  action,  proceeding  or claim against it arising out of, or relating in any
way  to, this Agreement shall be brought and enforced in the courts of the State
of  New York or of the United States of America for the Southern District of New
York,  and irrevocably submits to such jurisdiction, which jurisdiction shall be
exclusive.  The  Company,  the  Holder  and  any other registered Holders hereby
irrevocably  waive  any objection to such exclusive jurisdiction or inconvenient
forum.  Any  such  process  or summons to be served upon any of the Company, the
Holder  and  the  Holders  (at  the  option  of  the party bringing such action,
proceeding or claim) may be served by transmitting a copy thereof, by registered
or certified mail, return receipt requested, postage prepaid, addressed to it at
the  address  set  forth  in  Section  14  hereof.  Such mailing shall be deemed
personal  service and shall be legal and binding upon the party so served in any
action,  proceeding  or claim.  The Company, the Holder and any other registered
Holders  agree  that  the prevailing party(ies) in any such action or proceeding
shall  be  entitled  to  recover  from  the  other  party(ies) all of its'/their
reasonable  legal  costs  and expenses relating to such action or proceeding and
incurred  in  connection  with  the  preparation  therefore.

     18.     ENTIRE AGREEMENT; MODIFICATION.  This Agreement contains the entire
             ------------------------------
understanding  between  the  parties  hereto  with respect to the subject matter
hereof and may not be modified or amended except by a writing duly signed by the
party against whom enforcement of the modification or amendment is sought.

     19.     SEVERABILITY.  If  any provision of this Agreement shall be held to
             ------------
be  invalid  or  unenforceable,  such  invalidity  or unenforceability shall not
affect any other provision of this Agreement.

<PAGE>
     20.     CAPTIONS.  The  caption  headings of the Sections of this Agreement
             --------
are  for  convenience of reference only and are not intended, nor should they be
construed as, a part of this Agreement and shall be given no substantive effect.

     21.     BENEFITS  OF  THIS  AGREEMENT.  Nothing  in this Agreement shall be
             -----------------------------
construed  to  give  to any person or corporation other than the Company and the
Holder  and any other registered Holder(s) of the Warrant Certificates or Common
Stock  any  legal  or equitable right, remedy or claim under this Agreement; and
this  Agreement  shall be for the sole benefit of the Company and the Holder and
any other registered Holders of Warrant Certificates or Common Stock.

     22.     COUNTERPARTS.  This  Agreement  may  be  executed  in any number of
             ------------
counterparts  and  each of such counterparts shall for all purposes be deemed to
be  an original, and such counterparts shall together constitute but one and the
same  instrument.

     IN  WITNESS  WHEREOF,  the  parties hereto have caused this Agreement to be
duly executed, as of the day and year first above written.

                                 NEW YORK HEALTH CARE, INC.

                           By:   /s/_______________________________
                                    Name:     Jerry Braun
                                    Title:    Chief Executive Officer

                                 /s/_______________________________

<PAGE>
                                    EXHIBIT A

                     [FORM OF SERIES__ WARRANT CERTIFICATE]

THE  WARRANTS  REPRESENTED BY THIS CERTIFICATE AND THE OTHER SECURITIES ISSUABLE
UPON  EXERCISE  THEREOF  MAY  NOT  BE  OFFERED OR SOLD EXCEPT PURSUANT TO (i) AN
EFFECTIVE  REGISTRATION  STATEMENT UNDER THE SECURITIES ACT OF 1933, (ii) TO THE
EXTENT  APPLICABLE,  RULE 144 UNDER SUCH ACT (OR ANY SIMILAR RULE UNDER SUCH ACT
RELATING  TO  THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF
SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL FOR THE ISSUER, THAT AN
EXEMPTION  FROM  REGISTRATION  UNDER  SUCH  ACT  IS  AVAILABLE.

THE  TRANSFER  OR  EXCHANGE  OF  THE WARRANTS REPRESENTED BY THIS CERTIFICATE IS
RESTRICTED IN ACCORDANCE WITH THE WARRANT AGREEMENT REFERRED TO HEREIN.

                            EXERCISABLE ON OR BEFORE
                  5:00 P.M., NEW YORK TIME, SEPTEMBER 15, 2008

No.  ____                                        Series__ Warrant to Purchase
                                                 ________ Shares of Common Stock

                          SERIES__ WARRANT CERTIFICATE

     This Warrant Certificate certifies that ___________, or registered assigns,
is  the  registered  holder  of  _____________  (_______)  Warrants  to purchase
initially,  at any time from September 15, 2003 until 5:00 p.m. New York time on
September  15,  2008  ("Expiration  Date"),  up  to  _____________  (________)
fully-paid  and  non-assessable  shares of common stock, $.01 par value ("Common
Stock")  of  New York Health Care, Inc., a New York corporation (the "Company"),
at  the  initial  exercise  price,  subject to adjustment in certain events (the
"Exercise  Price"),  equal  to  $______ per share upon surrender of this Warrant
Certificate  and  payment  of  the  Exercise Price at an office or agency of the
Company,  but  subject  to  the  conditions  set forth herein and in the Warrant
Agreement  dated  as of September 15, 2003 between the Company and _____________
(the  "Warrant  Agreement").  Payment  of  the  Exercise  Price shall be made by
certified or official bank check in New York Clearing House funds payable to the
order of the Company or by surrender of this Warrant Certificate.

     No  Warrant  may  be  exercised  after  5:00  p.m.,  New  York time, on the
Expiration  Date,  at which time all Warrants evidenced hereby, unless exercised
prior thereto, hereby shall thereafter be void.

     The  Warrants  evidenced  by  this  Warrant  Certificate are part of a duly
authorized  issue  of  Warrants  issued pursuant to the Warrant Agreement, which
Warrant Agreement is hereby

<PAGE>
incorporated  by  reference  in and made a part of this instrument and is hereby
referred  to for a description of the rights, limitation of rights, obligations,
duties  and  immunities  thereunder  of  the  Company and the holders (the words
"holders"  or  "holder"  meaning the registered holders or registered holder) of
the  Warrants.

     The  Warrant  Agreement provides that upon the occurrence of certain events
the  Exercise Price and the type and number of the Company's securities issuable
thereupon  may,  subject to certain conditions, be adjusted.  In such event, the
Company  will,  at  the  request  of the holder, issue a new Warrant Certificate
evidencing  the  adjustment  in  the  Exercise  Price and the number and type of
securities  issuable  upon the exercise of the Warrants; provided, however, that
the  failure  of the Company to issue such new Warrant Certificates shall not in
any  way  change,  alter,  or  otherwise impair, the rights of the holder as set
forth  in  the  Warrant  Agreement.

     Upon  due  presentment  for  registration  of  transfer  of  this  Warrant
Certificate  at an office or agency of the Company, a new Warrant Certificate of
Warrant Certificates of like tenor and evidencing in the aggregate a like number
of  Warrants  shall  be issued to the transferee(s) in exchange for this Warrant
Certificate,  subject  to  the  limitations  provided  herein and in the Warrant
Agreement,  without  any  charge except for any tax or other governmental charge
imposed  in  connection  with  such  transfer.

     Upon  the  exercise  of  less  than  all  of the Warrants evidenced by this
Certificate,  the  Company  shall  forthwith  issue  to  the holder hereof a new
Warrant  Certificate  representing  such  numbered  unexercised  Warrants.

     The  Company  may  deem  and  treat  the registered holder(s) hereof as the
absolute  owner(s)  of this Warrant Certificate (notwithstanding any notation of
ownership  or  other  writing  hereon  made  by  anyone), for the purpose of any
exercise  hereof,  and  of any distribution to the holder(s) hereof, and for all
other  purposes,  and  the  Company  shall  not be affected by any notice to the
contrary.

     All terms used in this Warrant Certificate which are defined in the Warrant
Agreement  shall  have  the  meanings assigned to them in the Warrant Agreement.

     IN  WITNESS  WHEREOF, the Company has caused this Warrant Certificate to be
duly  executed  under  its  corporate  seal.

Dated as of September 15, 2003
Attest:                                        NEW YORK HEALTH CARE, INC.

/s/_____________________________         By:   /s/______________________________
Name:   Jacob Rosenberg                        Name:   Jerry Braun
Title:  Secretary                              Title:  Chief Executive Officer

<PAGE>
                              [FORM OF ASSIGNMENT]

             (To be executed by the registered holder if such holder
                  desires to transfer the Warrant Certificate.)

      FOR VALUE RECEIVED ___________________ hereby sells, assigns and unto

                  (Please print name and address of transferee

this  Warrant  Certificate, together with all right, title and interest therein,
and  does  hereby reasonably constitute and appoint ___________________________,
as  Attorney,  to  transfer  the  within Warrant Certificate on the books of the
within-named  Company,  with  full  power  of  substitution.

Date:                             Signature:
     -------------                          ------------------------------------
                                         (Signature must conform in all respects
                                          to name of holder as specified on the
                                          face of the Warrant Certificate.)

                                    (Insert Social Security or Other Identifying
                                    Number  of  Assignee)

<PAGE>
                         [FORM OF ELECTION TO PURCHASE]

     The  undersigned  hereby  irrevocably  elects  to  exercise  the  right,
represented  by  this  Warrant  Certificate,  to  purchase:

     _____________Shares
     _____________Series__  Warrants

and herewith tenders in payment for such securities a certified or official bank
check  payable  in New York Clearing House Funds to the order of New York Health
Care,  Inc.,  in  the  amount  of  $3.69 per share, or a total of ______________
shares  of  the  Securities  issuable  upon  exercise  of  the  Warrant,  all in
accordance  with  the  terms  of  the Warrant Agreement dated September 15, 2003
between  the  undersigned and New York Health Care, Inc. The undersigned request
that  a  certificate  for  such  Securities  be  registered  in  the  name  of
_________________ whose address is_________________ and that such Certificate be
delivered to _________________ whose address is _____________________.

Date:                         Signature:
     ------------                       -------------------------------------
                                    (Signature must conform in all respects
                                     to name of holder as specified on the
                                     face of the Warrant Certificate.)

                                    (Insert Social Security or Other Identifying
                                    Number  of  Assignee)

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]